Relay Therapeutics Ownership | Who Owns Relay Therapeutics?

Overview Forecast RevenueFinancials Chart

Relay Therapeutics Ownership Summary

Relay Therapeutics is owned by 95.44% institutional investors, 1.71% insiders, and 2.84% retail investors. Sb investment advisers (uk) is the largest institutional shareholder, holding 21.01% of RLAY shares. BB Biotech AG Ord is the top mutual fund, with 4.54% of its assets in Relay Therapeutics shares.

RLAY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Relay Therapeutics	95.44%	1.71%	2.84%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Sb investment advisers (uk)	27.90M	21.01%	$181.94M
Vanguard group	11.70M	8.81%	$76.32M
Blackrock	10.54M	7.94%	$68.74M
Casdin capital	8.45M	6.36%	$55.08M
Bellevue group	6.38M	4.80%	$41.58M
Price t rowe associates inc /md/	5.04M	3.79%	$32.85M
State street	4.25M	3.20%	$27.70M
Jpmorgan chase	3.96M	2.98%	$25.84M
Nextech invest	3.85M	2.90%	$25.08M
Norges bank	3.32M	2.50%	$21.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nextech invest	3.85M	4.22%	$25.08M
Casdin capital	8.45M	4.21%	$55.08M
Finepoint capital lp	1.61M	2.97%	$10.47M
Sb investment advisers (uk)	27.90M	1.68%	$181.94M
Bioimpact capital	1.27M	1.29%	$8.31M
Harbourvest partners	296.40K	1.03%	$1.93M
Bellevue group	6.38M	0.68%	$41.58M
Boxer capital	1.82M	0.62%	$11.86M
Braidwell lp	3.01M	0.61%	$19.60M
Alphabet	1.57M	0.52%	$10.23M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	3.32M	0.00%	3.32M
Casdin capital	8.45M	4.21%	1.02M
Voloridge investment management	1.19M	0.03%	984.43K
Millennium management	1.15M	0.00%	921.27K
Blackrock	10.54M	0.00%	746.46K

Top Sellers

Holder	Shares	% Assets	Change
Arrowmark colorado	541.12K	0.04%	-3.46M
Price t rowe associates inc /md/	5.04M	0.00%	-1.84M
State street	4.25M	0.00%	-1.77M
Jacobs levy equity management	-	-	-1.68M
Logos global management lp	-	-	-1.30M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	3.32M	0.00%	3.32M	$21.64M
Marshall wace, llp	276.70K	0.00%	276.70K	$1.80M
Squarepoint ops	144.99K	0.00%	144.99K	$945.31K
Thrivent financial for lutherans	120.01K	0.00%	120.01K	$782.00K
Mirae asset global etfs	56.11K	0.00%	56.11K	$364.24K

Sold Out

Holder	Change
Tfc financial management	-1.00
Parallel advisors	-14.00
Nelson, van denburg & campbell wealth management group	-18.00
Farther finance advisors	-25.00
First command advisory services	-25.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	178	-4.30%	126,768,728	-1.54%	95	0.99%	98	-3.92%	48	-
Mar 31, 2024	186	5.68%	128,755,897	1.37%	98	0.92%	102	18.60%	48	-17.24%
Dec 31, 2023	176	2.33%	127,011,599	-2.64%	103	0.91%	86	-4.44%	58	28.89%
Sep 30, 2023	172	4.24%	130,461,585	0.23%	106	0.93%	90	-2.17%	45	15.38%
Jun 30, 2023	165	1.85%	130,158,228	-0.61%	106	0.92%	92	27.78%	39	-25.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	7.38M	4.54%	1.00M
Vanguard Total Stock Mkt Idx Inv	4.89M	3.01%	904.00K
Vanguard Small Cap Index	3.87M	2.38%	682.81K
iShares Russell 2000 ETF	2.56M	1.54%	-5.77K
JPMorgan Small Cap Growth A	2.27M	1.40%	399.73K
Vanguard Small Cap Growth Index Inv	2.13M	1.31%	359.64K
T. Rowe Price New Horizons	2.12M	1.31%	259.85K
US Small-Cap Growth II Equity Comp	2.12M	1.31%	509.90K
SPDR® S&P Biotech ETF	1.99M	1.22%	21.98K
Vanguard Institutional Extnd Mkt Idx Tr	1.89M	1.17%	426.11K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 28, 2024	Rahmer Peter	See remarks	Sell	$9.82K
Oct 28, 2024	Catinazzo Thomas	Chief Financial Officer	Sell	$30.94K
Oct 28, 2024	Catinazzo Thomas	Chief Financial Officer	Sell	$10.28K
Oct 29, 2024	Catinazzo Thomas	Chief Financial Officer	Sell	$13.69K
Oct 28, 2024	Bergstrom Donald A	President, R&D	Sell	$16.29K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	6
2024 Q3	-	15
2024 Q2	-	12
2024 Q1	-	8
2023 Q4	-	8

RLAY Ownership FAQ

Who Owns Relay Therapeutics?

Relay Therapeutics shareholders are primarily institutional investors at 95.44%, followed by 1.71% insiders and 2.85% retail investors. The average institutional ownership in Relay Therapeutics's industry, Biotech Stocks , is 45.43%, which Relay Therapeutics exceeds.

Who owns the most shares of Relay Therapeutics?

Relay Therapeutics’s largest shareholders are Sb investment advisers (uk) (27.9M shares, 21.01%), Vanguard group (11.7M shares, 8.81%), and Blackrock (10.54M shares, 7.94%). Together, they hold 37.76% of Relay Therapeutics’s total shares outstanding.

Does Blackrock own Relay Therapeutics?

Yes, BlackRock owns 7.94% of Relay Therapeutics, totaling 10.54M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 68.74M$. In the last quarter, BlackRock increased its holdings by 746.46K shares, a 7.62% change.

Who is Relay Therapeutics’s biggest shareholder by percentage of total assets invested?

Nextech invest is Relay Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.22% of its assets in 3.85M Relay Therapeutics shares, valued at 25.08M$.

Who is the top mutual fund holder of Relay Therapeutics shares?

BB Biotech AG Ord is the top mutual fund holder of Relay Therapeutics shares, with 4.54% of its total shares outstanding invested in 7.38M Relay Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools